Clinical Trial Update: Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Apatinib combined with Nab-paclitaxel (albumin-bound paclitaxel) is being studied in Phase 1/2 for advanced triple-negative breast cancer and is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Apatinib (apatinib)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Advanced Triple Negative Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING